Ziprasidone hydrochloride dosage Reviews, Importers, Ziprasidone hcl dosage effects, Ziprasidone hcl drug dosage and interactions, apilist, Distributors, dosage Details, dosage warnings, dosage injection, bulk drugs suppliers, Ziprasidone hydrochloride side effects, api, Generic Products dosage, Molecular Formula C21H21ClN4OS.HCl;C21H22Cl2N4OS, Molecular Weight 449.40, CAS Registry Number 138982-67-9, Ziprasidone hcl dosage, Exporters, Directory dosage, patient, Ziprasidone hydrochloride dosage, Ziprasidone hcl dosage information by Taj Api

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

Ziprasidone-Hcl Taj API

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Ziprasidone Hcl Manufacturers in India Suppliers Ziprasidone Hcl Dossage Exporters Distributors Ziprasidone Hcl api active pharmaceuticals ingredients Ziprasidone Hcl manufacturers Side Effects bulk drugs raw material Dossage Ziprasidone Hcl companies Side Effects Dossage Importers Ziprasidone Hcl Dossage Ziprasidone Hcl Exporters Ziprasidone Hcl exporters Dossage FDA Dossage Ziprasidone Hcl Dossage DMF Symptoms Dossage Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Ziprasidone Hydrochloride manufacturing pharmaceutical drugs pharmaceutical intermediates Ziprasidone Hydrochloride pharmaceutical chemicals pharmaceutical raw materials Ziprasidone Hydrochloride active pharmaceutical ingredients Ziprasidone Hydrochloride committee active pharmaceutical ingredients manufacturer Ziprasidone Hydrochloride Active Pharmaceutical Ingredients manufacturer Ziprasidone Hydrochloride exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Ziprasidone Hcl, Ziprasidone Hcl manufacturer India, Ziprasidone Hcl product, Ziprasidone Hcl products, Api preparation, Certificate of Analysis API manufacturer product, Ziprasidone Hcl anti ulcer product, Certificate of Origin COA Ziprasidone Hcl COS Ziprasidone Hcl, pharmaceutical generic, pharmaceutical drug, medical, Ziprasidone Hcl pharma healthcare, pharma patents, contract MSDS manufacturing Trader Ziprasidone Hcl pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Ziprasidone Hcl expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Ziprasidone Hcl DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Ziprasidone Hcl ingredients, api, HIV Ziprasidone Hcl, tablets, capsules, syrup & protein Ziprasidone Hcl powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Ziprasidone Hcl gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Ziprasidone Hcl WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

taj pharma ltd. Ziprasidone-Hcl

HOME >> API >> API List 3 >> Ziprasidone Hcl >> Dosage

DOSAGE
Ziprasidone Hcl CAS Registry Number 138982-67-9

Ziprasidone comes as a capsule to take by mouth. It is usually taken twice a day with food. Take ziprasidone at around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take ziprasidone exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor may start you on a low dose of ziprasidone and gradually increase your dose.

Ziprasidone may help control your symptoms but will not cure your condition. Continue to take ziprasidone even if you feel well. Do not stop taking ziprasidone without talking to your doctor.

Ziprasidone Hcl Capsules should be administered at an initial daily dose of 20 mg BID with food. In some patients, daily dosage may subsequently be adjusted on the basis of individual clinical status up to 80 mg BID. Dosage adjustments, if indicated, should generally occur at intervals of not less than 2 days, as steady-state is achieved within 1 to 3 days. In order to ensure use of the lowest effective dose, ordinarily patients should be observed for improvement for several weeks before upward dosage adjustment.

Information Associated with Product:

DRUG DESCRIPTION

DOSAGE >>

SIDE EFFECTS

PRECAUTIONS

INTERACTION

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.